LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nanoparticles Heated by Radio Waves Kill Cells by Destroying Their DNA

By LabMedica International staff writers
Posted on 04 Nov 2008
Print article
A recent publication described the use of graphitic carbon-coated ferromagnetic cobalt nanoparticles to kill cells growing in tissue culture, which is the first step toward adapting the technique to destroy cancer cells in humans.

Investigators at the University of Arkansas (Little Rock, USA) used a catalytic chemical vapor deposition technique to synthesize cubic crystalline graphitic carbon-coated ferromagnetic cobalt nanoparticles (C–Co-NPs) with diameters of around seven nanometers. They used X-ray diffraction and X-ray photoelectron spectroscopy analysis to show that the cobalt nanoparticles inside the carbon shells were preserved in the metallic state. Then, they used fluorescence microscopy images and Raman spectroscopy to demonstrate that the nanoparticles effectively penetrated the cellular plasma membrane of cultured HeLa cells, both inside the cytoplasm and in the nucleus.

Data published in the October 29, 2008, issue of the journal Nanotechnology, revealed that low radio frequency (RF) radiation of 350 kHz induced localized heat into the metallic nanoparticles, which triggered the killing of the HeLa cells, a process that was found to be dependent on the RF application time and nanoparticle concentration. DNA gel electrophoresis assays of the HeLa cells after the RF treatment showed massive DNA fragmentation, which proved that the localized application of heat induced DNA damage and nucleus membrane disintegration.

"We have demonstrated that using a combination of a low frequency, low power radio frequency radiation – which has a high penetration ability in human tissue – with graphitic-magnetic composite nanoparticles could prove an excellent means of raising the temperature at the cellular level above the threshold required for DNA fragmentation or protein denaturation,” said senior author Dr. Alexandru Biris, assistant professor of applied science at the University of Arkansas. "The result is death of the cells. This technique is less invasive and possesses higher efficiency for targeting localized cells. It also has the potential to reduce the side effects associated with traditional cancer therapies.”

Related Links:
University of Arkansas


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Myeloperoxidase Assay
IDK MPO ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.